REVLIMID®
(lenalidomide) hard capsules
Consumer Medicine Information
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. This page contains answers to some common questions about Revlimid. It does not contain all the information that is known about Revlimid. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risk of you using this medicine against the benefits he/she expects it will have for you. If you have any concerns about using this medicine, ask your doctor or pharmacist. Bookmark or print this page, you may need to read it again.

WHAT REVLIMID IS USED FOR
Revlimid is supplied as hard capsules. Each capsule contains 5 mg, 10 mg, 15 mg or 25 mg of the active substance lenalidomide. Each pack contains 21 capsules. Revlimid belongs to a group of medicines called immunomodulating agents.
Revlimid is used in combination with another drug called dexamethasone to treat adult patients who have been diagnosed with Multiple Myeloma or MM (cancer of the bone marrow). It is prescribed for patients whose disease has progressed after one therapy.
Revlimid is also used to treat certain patients who have myelodysplastic syndromes (MDS). Patients with MDS have bone marrow that does not produce enough mature blood cells. This causes a lack of healthy blood cells that can function properly in the body. There are different types of MDS. Revlimid is approved to treat the type of MDS with a chromosome problem where part of chromosome 5 is missing. This type of MDS is known as deletion 5q MDS. Patients with this type of MDS often have low red blood cell counts that require treatment with blood transfusions and it is hoped that the use of Revlimid will reduce the need for these.
If you have any questions about how Revlimid works, or why this medicine has been prescribed for you, ask your doctor.
BEFORE YOU TAKE REVLIMID
Revlimid will only be prescribed to you by a doctor who has experience in medicines to treat cancers of the blood.
Follow all of your doctor's instructions carefully, even if they differ from the general information given in this leaflet.
Do not take Revlimid:
If you are allergic to lenalidomide or any of the other ingredients of Revlimid listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin. If you think you may be allergic, ask your doctor for advice
If you are, or suspect that you may be pregnant, or are able to become pregnant. This medicine may affect your baby if you take it while you are pregnant. Tell your doctor if you are pregnant or intend to become pregnant. See more details below.
If you are breast-feeding (see more details below).
If any of these apply to you, tell your doctor before you take Revlimid.
Do not take this medicine after the expiry date printed on the pack or if the packaging is torn or shows signs of tampering.
In that case, return it to your pharmacist.
Take special care with Revlimid:
You will have regular blood tests during treatment with Revlimid. Your doctor should ask you to have a blood test every week for the first 8 weeks of treatment with Revlimid and at least every month after that. Your doctor may adjust your dose of Revlimid or stop your treatment based on the results of your blood tests and on your general condition.
T